USA – The US Food and Drug Administration has rejected two proposed new cancer drugs developed in China, highlighting a tougher regulatory stance toward such drugs in the United States.…
Read MoreUSA – The US Food and Drug Administration has rejected two proposed new cancer drugs developed in China, highlighting a tougher regulatory stance toward such drugs in the United States.…
Read More